Li L, Ohman T, Deeb S S, Fukuchi K I
Dept of Comparative Medicine, Univ of Alabama at Birmingham, 35294, USA.
DNA Seq. 1999;10(4-5):219-28. doi: 10.3109/10425179909033951.
Mutations in the beta-amyloid precursor protein gene (APP) cause Alzheimer disease (AD) in certain families. The mature protein (APP) exists in several different isoforms resulting from alternative splicing of the primary transcript. Several lines of evidence indicate that particular isoform(s) of APP may contribute to the etiology of AD. One of the isoforms, APP695, lacks the Kunitz protease inhibitor (KPI) domain encoded by exon 7. APP695 is expressed predominantly in neurons, whereas the KPI domain containing isoforms, APP751 and APP770, are expressed ubiquitously. The ratio of APP751/APP695 mRNA tends to increase in the brain of AD patients. Furthermore, this ratio in mouse brain is much lower than that in human brain, and mice are resistant to the spontaneous development of beta-amyloidosis. In addition, transgenic mice that develop pathological changes similar to those of AD expressed more KPI-domain containing APP mRNA than transgenic mice without the changes. Previous studies imply that the controlling elements exist in the flanking sequences of the alternatively-spliced exons. Therefore, we have determined the DNA sequences of intron 7 and made a comparison between mouse and human DNA sequences of intron 7. Mouse intron 7 shares about 50% sequence identity with the human homologue, with higher sequence identity (approximately 85%) mainly in the 5' end (approximately 250 bp) of the intron. A palindromic sequence was found in both human and mouse intron 7 and showed subtle differences in their structure between the two species. Whether this sequence plays any roles in regulating alternative splicing of exon 7 remains to be determined. Human intron 7 contains a Alu element, which possesses potential retinoic acid and thyroid hormone responsive elements that might be involved in the regulation of alternative splicing. Mouse intron 7 sequence also contains a few repeat sequences which are specific to the genome of mice and rats. Homologies shared between human and mouse intron 7 sequences may contribute to the common characteristics of neuron-specific splicing of APP in both species. The unique features of the intron may account for differences between human and mouse brain in fine tuning of alternative splicing of the APP transcript, which may lead to their different susceptibilities to beta-amyloidosis.
β-淀粉样前体蛋白基因(APP)的突变在某些家族中会引发阿尔茨海默病(AD)。成熟蛋白(APP)存在于由初级转录本可变剪接产生的几种不同异构体中。多条证据表明,APP的特定异构体可能与AD的病因有关。其中一种异构体APP695缺乏外显子7编码的库尼茨蛋白酶抑制剂(KPI)结构域。APP695主要在神经元中表达,而含有KPI结构域的异构体APP751和APP770则在全身广泛表达。AD患者大脑中APP751/APP695 mRNA的比例往往会升高。此外,小鼠大脑中的这一比例远低于人类大脑,且小鼠对β-淀粉样变性的自发发展具有抗性。此外,出现与AD类似病理变化的转基因小鼠比未出现变化的转基因小鼠表达更多含有KPI结构域的APP mRNA。先前的研究表明,调控元件存在于可变剪接外显子的侧翼序列中。因此,我们测定了内含子7的DNA序列,并对小鼠和人类内含子7的DNA序列进行了比较。小鼠内含子7与人类同源物的序列同一性约为50%,较高的序列同一性(约85%)主要存在于内含子的5'端(约250 bp)。在人类和小鼠的内含子7中均发现了一个回文序列,且两种物种的该序列在结构上存在细微差异。该序列是否在调节外显子7的可变剪接中发挥任何作用仍有待确定。人类内含子7包含一个Alu元件,其具有潜在的视黄酸和甲状腺激素反应元件,可能参与可变剪接的调控。小鼠内含子7序列也包含一些小鼠和大鼠基因组特有的重复序列。人类和小鼠内含子7序列之间的同源性可能有助于两种物种中APP神经元特异性剪接的共同特征。内含子的独特特征可能解释了人类和小鼠大脑在APP转录本可变剪接精细调控方面的差异,这可能导致它们对β-淀粉样变性的易感性不同。